Nonproteolytic role for the urokinase receptor in cellular migration in vivo

American Journal of Respiratory Cell and Molecular Biology

Volumn 22, Issue 3, 2000, Pages 316-322

  Waltz, David A ^a,b,c   Fujita, Ross M ^a,b   Yang, Xuiwei ^a,b   Natkin, Lisa ^a,b   Zhuo, Shaoqiu ^a,b   Gerard, Craig J ^a,b   Rosenberg, Steven ^a,b   Chapman, Harold A ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b NOVARTIS PHARMA AG   (Switzerland)

^c BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMALIA; MURINAE; MUS MUSCULUS;

EID: 0034037536     PISSN: 10441549     EISSN: None     Source Type: Journal    
DOI: 10.1165/ajrcmb.22.3.3713     Document Type: Article

References (43)

1. 1. Saksela, O., and D. B. Rifkin. 1988. Cell-associated plasminogen activation: regulation and physiological functions. Annu. Rev. Cell Biol. 4:93-126.
2. 2. Idell, S., K. K. James, E. G. Levin, B. S. Schwartz, N. Manchanda, R. J. Maunder, T. R. Martin, J. McLarty, and D. S. Fair. 1989. Local abnormalities in coagulation and fibrinolytic pathways predispose to alveolar fibrin deposition in the adult respiratory distress syndrome. J. Clin. Invent. 84:695-705.
3. 3. Bertozzi, P., B. Astedt, L. Zenzius, K. Lynch, F. LeMaire, W. Zapol, and H. A. Chapman, Jr. 1990. Depressed bronchoalveolar urokinase activity in patients with adult respiratory distress syndrome [see comments]. N. Engl. J. Med. 322:890-897.
4. 4. Paranjpe, M., L. Engel, N. Young, and L. A. Liotta. 1980. Activation of human breast carcinoma collagenase through plasminogen activator. Life Sci. 26:1223-1231.
5. 5. Blasi, F., J. D. Vassalli, and K. Dano. 1987. Urokinase-type plasminogen activator: proenzyme, receptor, and inhibitors. J. Cell biol. 104:801-804.
6. 6. Ploug, M., E. Ronne, N. Bchrendt, A. L. Jensen, F. Blasi, and K. Dano. 1991. Cellular receptor for urokinase plasminogen activator: carboxyl-terminal processing and membrane anchoring by glycosyl-phosphatidylinositol. J. Biol. Chem. 266:1926-1933.
7. 7. Chapman, H. A. 1994. Dysregulation of the PA/PAI System in pulmonary disease (ARDS and fibrosis). In Fibrinolysis in Disease. P. Glas-Greenwalt, editor. CRC Press, New York. 253-259.
8. 8. Estreicher, A., J. Muhlhauser, J. L. Carpentier, L. Orcí, and J. D. Vassalli. 1990. The receptor for urokinase type plasminogen activator polarizes expression of the protease to the leading edge of migrating monocytes and promotes degradation of enzyme inhibitor complexes. J. Cell Biol. 111: 783-792.
9. 9. Gyetko, M. R., R. F. Todd III, C. C. Wilkinson, and R. G. Sitrin. 1994. The urokinase receptor is required for human monocyte chemotaxis in vitro. J. Clin. Invest. 93:1380-1387.
10. 10. Romer, J., T. H. Bugge, C. Pyke, L. R. Lund, M. J. Flick, J. L. Degen, and K. Dano. 1996. Impaired wound healing in mice with a disrupted plasminogen gene [see comments]. Nat. Med. 2:287-292.
11. 11. Vassalli, J. D., A. P. Sappino, and D. Belin. 1991. The plasminogen activator/plasmin system. J. Clin. Invest. 88:1067-1072.
12. 12. Blasi, F. 1993. Urokinase and urokinase receptor: a paracrine/autocrine system regulating cell migration and invasiveness. Bioessays 15:105-111.
13. 13. Waltz, D. A., and H. A. Chapman. 1994. Reversible cellular adhesion to vitronectin linked to urokinase receptor occupancy. J. Biol. Chem. 269:14746-14750.
14. 14. Wei, Y., D. A. Waltz, N. Rao, R. J. Drummond, S. Rosenberg, and H. A. Chapman. 1994. Identification of the urokinase receptor as an adhesion receptor for vitronectin. J. Biol. Chem. 269:32380-32388.
15. 15. Gudewicz, P. W., and N. Gilboa. 1987. Human urokinase-type plasminogen activator stimulates chemotaxis of human neutrophils. Biochem. Biophys. Res. Commun. 147:1176-1181.
16. 16. Fazioli, F., M. Resnati, N. Sidenius, Y. Higashimoto, E. Appella, and F. Blasi. 1997. A urokinase-sensitive region of the human urokinase receptor is responsible for its chemotactic activity. EMBO J. 16:7279-7286.
17. 17. Crowley, C. W., R. L. Cohen, B. K. Lucas, G. Liu, M. A. Shuman, and A. D. Levinson. 1993. Prevention of metastasis by inhibition of the urokinase receptor. Proc. Natl. Acad. Sci. USA 90:5021-5025.
18. 18. Waltz, D. A., L. R. Natkin, R. M. Fujita, Y. Wei, and H. A. Chapman. 1997. Plasmin and plasminogen activator inhibitor type 1 promote cellular motility by regulating the interaction between the urokinase receptor and vitronectin. J. Clin. Invest. 100:58-67.
19. 19. May, A. E., S. M. Kanse, L. R. Lund, R. H. Gisler, B. A. Imhof, and K. T. Preissner. 1998. Urokinase receptor (CD87) regulates leukocyte recruitment via beta 2 integrins in vivo. J. Exp. Med. 188:1029-1037.
20. 20. Bozic, C. R., L. F. Kolakowski, Jr., N. P. Gerard, C. Garcia-Rodriguez, C. von Uexkull-Guldenband, M. J. Conklyn, R. Breslow, H. J. Showell, and C. Gerard. 1995. Expression and biologic characterization of the murine chemokine KC. J. Immunol. 154:6048-6057.
21. 21. Min, H. Y., L. V. Doyle, C. R. Vitt, C. L. Zandonella, J. R. Stratton-Thomas, M. A. Shuman, and S. Rosenberg. 1996. Urokinase receptor antagonists inhibit angiogenesis and primary tumor growth in syngeneic mice. Cancer Res. 56:2428-2433.
22. 22. Carmeliet, P., L. Schoonjans, L. Kieckens, B. Ream, J. Degen, R. Bronson, R. De Vos, J. J. van den Oord, D. Collen, and R. C. Mulligan. 1994. Physiological consequences of loss of plasminogen activator gene function in mice. Nature 368:419-424.
23. 23. Dewerchin, M., A. V. Nuffelen, G. Wallays, A. Bouche, L. Moons, P. Carmeliet, R. C. Mulligan, and D. Collen. 1996. Generation and characterization of urokinase receptor-deficient mice. J. Clin. Invest. 97:870-878.
24. 24. Stratton-Thomas, J. R., H. Y. Min, S. E. Kaufman, C. Y. Chiu, G. T. Mullenbach, and S. Rosenberg. 1995. Yeast expression and phagemid display of the human urokinase plasminogen activator epidermal growth factor-like domain. Protein Eng. 8:463-470.
25. 25. Gaertner, H. F., and R. E. Offord. 1996. Site-specific attachment of functionalized poly(ethylene glycol) to the amino terminus of proteins. Bioconjug. Chem. 7:38-44.
26. 26. Bozic, C. R., B. Lu, U. E. Hopken, C. Gerard, and N. P. Gerard. 1996. Neurogenic amplification of immune complex inflammation. Science 273:1722-1725.
27. 27. Motulsky, H. 1995. Intuitive Biostatistics. Oxford University Press, New York. 207-213.
28. 28. Gyetko, M. R., R. G. Sitrin, J. A. Fuller, R. F. Todd III, H. Petty, and T. J. Standiford. 1995. Function of the urokinase receptor (CD87) in neutrophil chemotaxis. J. Leukoc. Biol. 58:533-538.
29. 29. Conese, M., A. Nykjaer, C. M. Petersen, O. Cremona, R. Pardi, P. A. Andreasen, J. Gliemann, E. I. Christensen, and F. Blasi. 1995. Alpha-2 macroglobulin receptor/LDL receptor-related protein (LRP)-dependent internalization of the urokinase receptor. J. Cell Biol. 131:1609-1622.
30. 30. Okada, S. S., S. R. Grobmyer, and E. S. Barnathan. 1996. Contrasting effects of plasminogen activators, urokinase receptor, and LDL receptor-related protein on smooth muscle cell migration and invasion. Arterioscler. Thromb. Vasc. Biol. 16:1269-1276.
31. 31. Wijnberg, M. J., P. H. Quax, N. M. Nieuwenbrock, and J. H. Verheijen. 1997. The migration of human smooth muscle cells in vitro is mediated by plasminogen activation and can he inhibited by alpha2-macroglobulin receptor associated protein. Thromb. Haemost. 78:880-886.
32. 32. Waltz, D. A., L. Z. Sailor, and H. A. Chapman. 1993. Cytokines induce urokinase-dependent adhesion of human myeloid cells: a regulatory role for plasminogen activator inhibitors. J. Clin. Invest. 91:1541-1552.
33. 33. Resnati, M., M. Guttinger, S. Valcamonica, N. Sidenius, F. Blasi, and F. Fazioli. 1996. Proteolytic cleavage of the urokinase receptor substitutes for the agonist-induced chemotactic effect. EMBO J. 15:1572-1582.
34. 34. Simon, D. I., N. K. Rao, H. Xu, Y. Wei, O. Majdic, E. Ronne, L. Kobzik, and H. A. Chapman. 1996. Mac-1 (CD11b/CD18) and the urokinase receptor (CD87) form a functional unit on monocytic cells. Blood 88:3185-3194.
35. 35. Wei, Y., M. Lukashev, D. I. Simon, S. C. Bodary, S. Rosenberg, M. V. Doyle, and H. A. Chapman. 1996. Regulation of integrin function by the urokinase receptor. Science 273:1551-1555.
36. 36. Koshelnick, Y., M. Ehart, P. HufnagI, P. C. Heinrich, and B. R. Binder. 1997. Urokinase receptor is associated with the components of the JAK1/ STAT1 signaling pathway and leads to activation of this pathway upon receptor clustering in the human kidney epithelial tumor cell line TCL-598. J. Biol. Chem. 272:28563-28567.
37. 37. Dumler, I., A. Weis, O. A. Mayboroda, C. Maasch, U. Jerke, H. Haller, and D. C. Gulba. 1998. The Jak/Stat pathway and urokinase receptor signaling in human aortic vascular smooth muscle cells. J. Biol. Chem. 273:315-321.
38. 38. Lu, H., C. W. Smith, J. Perrard, D. Bullard, L. Tang, S. B. Shappell, M. L. Entman, A. L. Beaudet, and C. M. Ballantyne. 1997. LFA-1 is sufficient in mediating neulrophil emigration in Mac-1-deficient mice. J. Clin. Invest. 99:1340-1350.
39. 39. Doerschuk, C. M., W. M. Quinlan, N. A. Doyle, D. C. Bullard, D. Vestweber, M. L. Jones, F. Takei, P. A. Ward, and A. L. Beaudet. 1996. The role of P-selectin and ICAM-1 in acute lung injury as determined using blocking antibodies and mutant mice. J. Immunol. 157:4609-4614.
40. 40. Singer, S. J., and A. Kupfer. 1986. The directed migration of eukaryotic cells. Annu. Rev. Cell Biol. 2:337-365.
41. 41. Xue, W., A. L. Kindzelskii, R. F. Todd III, and H. R. Petty. 1994. Physical association of complement receptor type 3 and urokinase-type plasminogen activator receptor in neutrophil membranes. J. Immunol. 152:4630-4640.
42. 42. Li, C., J. N. Liu, and V. Gurewich. 1995. Urokinase-type plasminogen activator-induced monocyte adhesion requires a carboxyl-terminal lysine and cAMP-dependent signal transduction. J. Biol. Chem. 270:30282-30285.
43. 43. Nguyen, D. H., I. M. Hussaini, and S. L. Gonias. 1998. Binding of urokinase-type plasminogen activator to its receptor in MCF-7 cells activates extracellular signal-regulated kinase 1 and 2 which is required for increased cellular motility. J. Biol. Chem. 273:8502-8507.